GENOMEKEY

genomekey-logo

GenomeKey is an award-winning, early-phase company that is exploiting innovative genomic technology and cutting-edge AI machine learning to address critical healthcare challenges.

#SimilarOrganizations #People #Financial #Website #More

GENOMEKEY

Social Links:

Industry:
Artificial Intelligence Bioinformatics Biotechnology Health Care Machine Learning

Founded:
2019-01-01

Address:
Bristol, Bristol, City Of, United Kingdom

Country:
United Kingdom

Website Url:
http://www.genomekey.com

Total Employee:
1+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
9.5 M USD

Technology used in webpage:
IPv6 Google Apps For Business Microsoft Azure DNS Cloudflare Hosting Cloudflare DNS


Similar Organizations

genome-key-logo

Genome Key

GenomeKey is an award-winning company that is exploiting innovative genomic technology

menten-ai-logo

Menten AI

Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.

pieces-logo

Pieces

Pieces is a healthcare artificial intelligence and technology company.

Current Employees Featured

david-davies_image

David Davies
David Davies Chief Operating Officer @ GenomeKey
Chief Operating Officer
2021-01-01

chris-heys_image

Chris Heys
Chris Heys CTO @ GenomeKey
CTO

david-davies_image

David Davies
David Davies COO @ GenomeKey
COO

michael-roberts_image

Michael Roberts
Michael Roberts CEO @ GenomeKey
CEO

Founder


chris-heys_image

Chris Heys

david-davies_image

David Davies

michael-roberts_image

Michael Roberts

Investors List

carb-x_image

CARB-X

CARB-X investment in Grant - GenomeKey

Official Site Inspections

http://www.genomekey.com

  • Host name: 104.21.30.33
  • IP address: 104.21.30.33
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "GenomeKey"

Transformative Diagnostics - IVD device | GenomeKey

GenomeKey awarded US$11.4M from global non-profit CARB-X GenomeKey is developing a โ€ฆSee details»

Transformative diagnostics | GenomeKey

Founded in 2019, GenomeKey brought together scientists, engineers, and clinicians to build a next generation diagnostic device that would transform how we treat sepsis. We realised early on that the twin revolutions in DNA โ€ฆSee details»

GenomeKey - Crunchbase Company Profile & Funding

Organization. GenomeKey . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... GenomeKey is โ€ฆSee details»

Meet the team - GenomeKey

Prior to GenomeKey, she served as the Partnerships and Delivery Operations Lead at the โ€ฆSee details»

Genome Key - Crunchbase Company Profile & Funding

Organization. Genome Key . Connect to CRM . Save . Summary. Financials. People. โ€ฆSee details»

GenomeKey Company Profile 2024: Valuation, Funding โ€ฆ

GenomeKey is a Private company. What is the current valuation of GenomeKey? The current valuation of GenomeKey is . What is GenomeKeyโ€™s current revenue? The current revenue for GenomeKey is . How much funding has GenomeKey โ€ฆSee details»

GenomeKey - Company Profile - Tracxn

Dec 11, 2024 GenomeKey - Developer of diagnostic solutions for infectious diseases by โ€ฆSee details»

GenomeKey - The Org

GenomeKey is an award-winning, early-phase company that is exploiting innovative genomic โ€ฆSee details»

GenomeKey - Funding, Financials, Valuation & Investors

GenomeKey is an award-winning, early-phase company that is exploiting innovative genomic โ€ฆSee details»

GenomeKey - Leadership Team - The Org

The Leadership Team at GenomeKey steers the company's strategic vision and direction, โ€ฆSee details»

GenomeKey - Products, Competitors, Financials, Employees, โ€ฆ

GenomeKeyโ€™s innovative technology aims to accelerate diagnosis and deliver vital antibacterial โ€ฆSee details»

GenomeKey - Raised $259K Funding from 2 investors - Tracxn

Dec 5, 2024 GenomeKey has raised a total funding of $259K over 4 rounds from 2 investors. โ€ฆSee details»

GenomeKey awarded $11.4M to transform sepsis diagnosis and โ€ฆ

Jul 31, 2024 GenomeKey has been awarded a major grant from Combating Antibiotic โ€ฆSee details»

Partnerships in Diagnostics | GenomeKey

GenomeKey awarded US$11.4M from global non-profit CARB-X GenomeKey is developing a โ€ฆSee details»

GenomeKey - Contacts, Employees, Board Members, Advisors

GenomeKey is an award-winning, early-phase company that is exploiting innovative genomic โ€ฆSee details»

GenomeKey - Overview, News & Similar companies | ZoomInfo.com

GenomeKey enables targeted Sepsis treatment in hours, rather than days. This is important โ€ฆSee details»

GenomeKey

NOT FOR CLINICAL USE - RESEARCH USE ONLY Log in. Email Address: Password:See details»

GenomeKey - Tech Stack, Apps, Patents & Trademarks - Crunchbase

Dec 10, 2024 Organization. GenomeKey . Connect to CRM . Save . Summary. Financials. โ€ฆSee details»

AI diagnostic solution - GenomeKey

GenomeKey is developing an innovative new in vitro diagnostic device which will reduce the โ€ฆSee details»

GenomeKey Platform

Features of GenomeKey: Precision at Speed: Harness our proprietary machine learning โ€ฆSee details»

linkstock.net © 2022. All rights reserved